Delivery Order SPE2DB24D1007-SPE2DB24FBZWW
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA), a Department of Defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA), a U.S. Department of Defense (DoD) agency. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $1,462.22 and is a firm fixed-price delivery order, with a completion date of May 15, 2024. This award is not associated with a...
This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $18,994.30 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 21, 2024 and was awarded on November 20, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $1,372.38. The contract is a Firm Fixed Price Delivery Order with a performance period ending on June 27, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $1,840.12 firm fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 15, 2022. There is no set-aside designation indicated for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $4,601.54, is a firm-fixed-price delivery order with an ultimate completion date of June 15, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a child award under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply RESTASIS 0.05% eye emulsion to the U.S. government. The Delivery Order contract, valued at $4,363.48, was awarded on May 30, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of May 31, 2024. This contract is not set-aside and is awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at...
This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion in 60-count packages to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price and a ceiling value of $1,080.36. It has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,735.65 and has been awarded as a Firm Fixed Price Delivery Order with an ultimate completion date of December 18, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of RESTASIS 0.05% Eye Emulsion to the Defense Logistics Agency (DLA). The $3,519 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 23, 2022 and was awarded on August 22, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...